Investigation of XPD, MiR-145 and MiR-770 Expression in Patients with End-stage Renal Disease

Overview

Journal Mol Biol Rep

Specialty Molecular Biology

Date 2023 Jul 1

PMID 37392287

Authors

Elif Citak

Serkan Feyyaz Yalin

Mehmet Riza Altiparmak

Mehmet Guven

Affiliations

Soon will be listed here.

Abstract

Background: The effective maintenance of genome integrity and fidelity is vital for the normal function of our tissues and organs, and the prevention of diseases. DNA repair pathways maintain genome stability, and the adequacy of genes acting in these pathways is essential for disease suppression and direct treatment responses. Chronic kidney disease is characterized by high levels of genomic damage. In this study, we examined the expression levels of the xeroderma pigmentosum group D (XPD) gene, which plays a role in the nucleotide excision repair (NER) repair mechanism, and the expression levels of miR-145 and miR-770 genes, which play a role in the regulation of the expression of the XPD gene, in hemodialysis patients with (n = 42) and without malignancy (n = 9) in pre- and post-dialysis conditions. We also evaluated these values with the clinical findings of the patients.

Methods & Results: Gene expression analysis was performed by real-time polymerase chain reaction (qRT-PCR). Compared to the individuals with normal kidney function (2.06 ± 0.32), the XPD gene expression was lower in the pre-dialysis condition both in hemodialysis patients without cancer (1.24 ± 0.18; p = 0.02) and in hemodialysis patients with cancer (0.82 ± 0.114; p = 0.001). On the other hand, we found that miR-145 and miR-770 expression levels were high in both groups. We also found that expression levels were affected by dialysis processes. A statistically significant positive correlation was found between miR-145 and mir770 expression levels in the pre-dialysis group of patients with (r=-0.988. p = 0.0001) and without (r=-0.934. p = 0.0001) malignancy.

Conclusions: Studies on DNA damage repair in the kidney will help develop strategies to protect kidney function against kidney diseases.

Citing Articles

Investigation of APE1 and OGG1 expression in chronic hemodialysis patients.

Rostami M, Yalin S, Altiparmak M, Guven M Mol Biol Rep. 2024; 51(1):144.

PMID: 38236479 DOI: 10.1007/s11033-023-09152-3.

References

Guven G, Altiparmak M, Trabulus S, Yalin A, Batar B, Tunckale A . Relationship between genomic damage and clinical features in dialysis patients. Genet Test Mol Biomarkers. 2013; 17(3):202-6. DOI: 10.1089/gtmb.2012.0301. View

Luciani A, Denley M, Govers L, Sorrentino V, Froese D . Mitochondrial disease, mitophagy, and cellular distress in methylmalonic acidemia. Cell Mol Life Sci. 2021; 78(21-22):6851-6867. PMC: 8558192. DOI: 10.1007/s00018-021-03934-3. View

Shirazian S, Starakiewicz P, Latcha S . Cancer Screening in End-Stage Kidney Disease. Adv Chronic Kidney Dis. 2022; 28(5):502-508.e1. DOI: 10.1053/j.ackd.2021.09.006. View

Vamvakas S, Bahner U, Heidland A . Cancer in end-stage renal disease: potential factors involved -editorial-. Am J Nephrol. 1998; 18(2):89-95. DOI: 10.1159/000013314. View

Hayashi K, Hishikawa A, Itoh H . DNA Damage Repair and DNA Methylation in the Kidney. Am J Nephrol. 2019; 50(2):81-91. DOI: 10.1159/000501356. View

Schmid U, Stopper H, Schweda F, Queisser N, Schupp N . Angiotensin II induces DNA damage in the kidney. Cancer Res. 2008; 68(22):9239-46. DOI: 10.1158/0008-5472.CAN-08-1310. View

Duan M, Speer R, Ulibarri J, Liu K, Mao P . Transcription-coupled nucleotide excision repair: New insights revealed by genomic approaches. DNA Repair (Amst). 2021; 103:103126. PMC: 8205993. DOI: 10.1016/j.dnarep.2021.103126. View

Vogel U, Dybdahl M, Frentz G, Nexo B . DNA repair capacity: inconsistency between effect of over-expression of five NER genes and the correlation to mRNA levels in primary lymphocytes. Mutat Res. 2000; 461(3):197-210. DOI: 10.1016/s0921-8777(00)00051-3. View

Compe E, Pangou E, Le May N, Elly C, Braun C, Hwang J . Phosphorylation of XPD drives its mitotic role independently of its DNA repair and transcription functions. Sci Adv. 2022; 8(33):eabp9457. PMC: 9385140. DOI: 10.1126/sciadv.abp9457. View

10.

Franczyk B, Gluba-Brzozka A, Olszewski R, Parolczyk M, Rysz-Gorzynska M, Rysz J . miRNA biomarkers in renal disease. Int Urol Nephrol. 2021; 54(3):575-588. PMC: 8831254. DOI: 10.1007/s11255-021-02922-7. View

11.

Marteijn J, Lans H, Vermeulen W, Hoeijmakers J . Understanding nucleotide excision repair and its roles in cancer and ageing. Nat Rev Mol Cell Biol. 2014; 15(7):465-81. DOI: 10.1038/nrm3822. View

12.

Kralund H, Ousager L, Jaspers N, Raams A, Pedersen E, Gade E . Xeroderma Pigmentosum-Trichothiodystrophy overlap patient with novel XPD/ERCC2 mutation. Rare Dis. 2014; 1:e24932. PMC: 3916142. DOI: 10.4161/rdis.24932. View

13.

Dalgliesh G, Furge K, Greenman C, Chen L, Bignell G, Butler A . Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature. 2010; 463(7279):360-3. PMC: 2820242. DOI: 10.1038/nature08672. View

14.

Kondo D, Noguchi A, Tamura H, Tsuchida S, Takahashi I, Kubota H . Elevated Urinary Levels of 8-Hydroxy-2'-deoxyguanosine in a Japanese Child of Xeroderma Pigmentosum/Cockayne Syndrome Complex with Infantile Onset of Nephrotic Syndrome. Tohoku J Exp Med. 2016; 239(3):231-5. DOI: 10.1620/tjem.239.231. View

15.

Corredor Z, da Silva Filho M, Rodriguez-Ribera L, Catalano C, Hemminki K, Coll E . Loci associated with genomic damage levels in chronic kidney disease patients and controls. Mutat Res Genet Toxicol Environ Mutagen. 2020; 852:503167. DOI: 10.1016/j.mrgentox.2020.503167. View

16.

Radwan W, Elbarbary H, Alsheikh N . DNA repair genes XPD and XRCC1 polymorphisms and risk of end-stage renal disease in Egyptian population. Ren Fail. 2014; 37(1):122-8. DOI: 10.3109/0886022X.2014.967646. View

17.

Shi S, Yu L, Chiu C, Sun Y, Chen J, Khitrov G . Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. J Am Soc Nephrol. 2008; 19(11):2159-69. PMC: 2573016. DOI: 10.1681/ASN.2008030312. View

18.

Ho J, Ng K, Rosen S, Dostal A, Gregory R, Kreidberg J . Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury. J Am Soc Nephrol. 2008; 19(11):2069-75. PMC: 2573018. DOI: 10.1681/ASN.2008020162. View

19.

Chen N, Kiattisunthorn K, ONeill K, Chen X, Moorthi R, Gattone 2nd V . Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD). PLoS One. 2013; 8(5):e64558. PMC: 3661525. DOI: 10.1371/journal.pone.0064558. View

20.

Xu W, Hua Y, Deng F, Wang D, Wu Y, Zhang W . MiR-145 in cancer therapy resistance and sensitivity: A comprehensive review. Cancer Sci. 2020; 111(9):3122-3131. PMC: 7469794. DOI: 10.1111/cas.14517. View